Shares of Medtronic PLC MDT slipped 1.90% to $91.51 Wednesday, on what proved to be an all-around mixed trading session for ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...

Medtronic is a diversified medical device maker with a global footprint. Its reliably growing dividend has helped fuel its stock performance for decades. Its shares are reasonably valued for the ...

A pediatric arterial filter for the most magical patients, the Affinity Pixie arterial filter features ease of prime and effective air handling and filtration. The filter’s maximum recommended ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of $105.00. The company’s shares closed ...

The Green Party's new logo is an emoji. The federal party unveiled its new brand, a green dot, on Tuesday on Parliament Hill, possibly weeks before a snap federal election. "The great thing about ...

Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business.